145 related articles for article (PubMed ID: 12176808)
21. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
22. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
[TBL] [Abstract][Full Text] [Related]
23. Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
Marchesoni A; Battafarano N; Arreghini M; Pellerito R; Cagnoli M; Prudente P; Cerase A; Priolo F; Tosi S
Arthritis Rheum; 2002 Feb; 47(1):59-66. PubMed ID: 11932879
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study.
Nikas SN; Voulgari PV; Alamanos Y; Papadopoulos CG; Venetsanopoulou AI; Georgiadis AN; Drosos AA
Ann Rheum Dis; 2006 Feb; 65(2):257-60. PubMed ID: 15975964
[TBL] [Abstract][Full Text] [Related]
26. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
Maini RN; Breedveld FC; Kalden JR; Smolen JS; Furst D; Weisman MH; St Clair EW; Keenan GF; van der Heijde D; Marsters PA; Lipsky PE;
Arthritis Rheum; 2004 Apr; 50(4):1051-65. PubMed ID: 15077287
[TBL] [Abstract][Full Text] [Related]
27. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M;
Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
[TBL] [Abstract][Full Text] [Related]
28. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis.
Abe T; Takeuchi T; Miyasaka N; Hashimoto H; Kondo H; Ichikawa Y; Nagaya I
J Rheumatol; 2006 Jan; 33(1):37-44. PubMed ID: 16395748
[TBL] [Abstract][Full Text] [Related]
29. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
30. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.
Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P
J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805
[TBL] [Abstract][Full Text] [Related]
31. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
32. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
[TBL] [Abstract][Full Text] [Related]
33. Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Clin Exp Rheumatol; 2006; 24(5):529-33. PubMed ID: 17181921
[TBL] [Abstract][Full Text] [Related]
34. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
[TBL] [Abstract][Full Text] [Related]
35. An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.
Sidiropoulos PI; Siakka P; Raptopoulou A; Mamoulaki M; Choulaki C; Koutala H; Kouroumali H; Kritikos H; Boumpas DT
Ann Rheum Dis; 2006 Apr; 65(4):538-41. PubMed ID: 16126800
[TBL] [Abstract][Full Text] [Related]
36. Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit.
Sidiropoulos P; Bertsias G; Kritikos HD; Kouroumali H; Voudouris K; Boumpas DT
Ann Rheum Dis; 2004 Feb; 63(2):144-8. PubMed ID: 14722202
[TBL] [Abstract][Full Text] [Related]
37. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
Peters MJ; Vis M; van Halm VP; Wolbink GJ; Voskuyl AE; Lems WF; Dijkmans BA; Twisk JW; de Koning MH; van de Stadt RJ; Nurmohamed MT
Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
[TBL] [Abstract][Full Text] [Related]
38. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
Mack ME; Hsia E; Aletaha D
Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy and safety of infliximab in patients with rheumatoid arthritis].
Zhang W; Shi Q; Wu DH; Bao CD; Yang NP; Li ZG; Zhu P; Zhang X; Huang CB; He DY; Ye ZZ; Tao Y; Fang YF; Gu JR; Wu HX; Sun LY; Yang XY; Huang F; Xu HJ; Zhao DB; Zhang MJ; Zheng Y; Ai MX; Lu J; Zhang FC
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1876-80. PubMed ID: 19953907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
